Fatigue in multiple sclerosis – Insights into evaluation and management
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Nitsche, M. A., & Paulus, W. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-1-00633.x · Cited by 5,656
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Development of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Self-citationThe impact of fatigue on patients with multiple sclerosis
Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100048691 · Cited by 1,025
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985
The measurement of fatigue: a new instrument
Schwartz, J. E., Jandorf, L., & Krupp, L. B. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90104-n · Cited by 562
Benedict, R. H. B., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., & Weinstock-Guttman, B. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.12.009 · Cited by 528
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514564487 · Cited by 519
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
Evaluation of the modified fatigue impact scale in four different European countries
Kos, D., Kerckhofs, E., Carrea, I., Verza, R., Ramos, M., & Jansa, J. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1117oa · Cited by 381
Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
Stankoff, B., Waubant, E., Confavreux, C., Edan, G., Debouverie, M., Rumbach, L., Moreau, T., Pelletier, J., Lubetzki, C., Clanet, M., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000158272.27070.6a · Cited by 318 · cited 31×
“Neurophysiologie Clinique/Clinical Neurophysiology (2 erum carnitine levels and fatigue manifestation [42,163]. ence, this agent seemed appealing for Tomassini et al. ho performed a randomized crossover placebo-controlled rial, aiming to examine the efficacy of acetyl-l-carnitine e b p U PRESS S.S. Ayache, M.A. Chalah…”
InfluentialThe dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders
Dobryakova, E., Genova, H. M., DeLuca, J., & Wylie, G. R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00052 · Cited by 242
Malaguarnera, M., Cammalleri, L., Gargante, M. P., Vacante, M., Colonna, V., & Motta, M. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.6.1738 · Cited by 142
Fatigue in MS is related to sympathetic vasomotor dysfunction
Flachenecker, P., Rufer, A., Bihler, I., Hippel, C., Reiners, K., Toyka, K. V., & Kesselring, J. (2003) · Neurology · doi:10.1212/01.wnl.0000080365.95436.b8 · Cited by 125
Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis
Ehde, D. M., Kraft, G. H., Chwastiak, L., Sullivan, M. D., Gibbons, L. E., Bombardier, C. H., & Wadhwani, R. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.08.002 · Cited by 107
Oral L-Carnitine: Metabolite Formation and Hemodialysis
Bain, M., Faull, R., Milne, R., & Evans, A. (2006) · Current Drug Metabolism · doi:10.2174/138920006778520561 · Cited by 29
Cited by
Kappos, L., Fox, R. J., Burcklen, M., Freedman, M. S., Havrdová, E. K., Hennessy, B., Hohlfeld, R., Lublin, F., Montalban, X., Pozzilli, C., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0405 · Cited by 228
Snow, N. J., Wadden, K. P., Chaves, A. R., & Ploughman, M. (2019) · Neural Plasticity · doi:10.1155/2019/6430596 · Cited by 56
Linnhoff, S., Haghikia, A., & Zaehle, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-32779-y · Cited by 11
Fatigue: Pharmacological and non-pharmacological management in patients with multiple sclerosis
Yeni, K. (2024) · Advanced Neurology · doi:10.36922/an.2576 · Cited by 2
Metadata
- Authors
- Ayache, S. S., & Chalah, M. A.
- Venue
- Neurophysiologie Clinique/Clinical Neurophysiology
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 47
- Issue
- 2
- Pages
- 139-171
- ISSN
- 0987-7053 (ISSN-L)
- OpenAlex
- W2605804610
- Cited by
- 161
- References
- 19
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.